Chronic Total Occlusion Intervention for Coronary Artery Disease
(PROGRESS-CTO Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiated registry is to collect information on treatment strategies and outcomes of consecutive patients undergoing CTO PCI among various participating centers. The information collected will be used to determine the frequency of CTO PCI performed at the participating sites and examine the procedural strategies utilized, and the procedural (both immediate and during follow-up) outcomes.
Who Is on the Research Team?
Emmanouil S Brilakis, MD, PhD
Principal Investigator
Minneapolis Heart Institute Foundation
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs)
Follow-up
Participants are monitored for major adverse cardiovascular events (MACE) and procedural success after PCI
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Minneapolis Heart Institute Foundation
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.